JPRN-UMIN000006381已完成未知
Phase 2 study of amrubicin in previously treated patients with malignant pleural mesothelioma - Phase 2 study of amrubicin in previously treated patients with malignant pleural mesothelioma
agasaki University Hospital0 个研究点目标入组 32 人开始时间: 2011年9月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Symptomatic pericardial effusion 2.Symptomatic SVC syndrome required emergency radiation 3.Serious medical complications 4.Uncontrolled angina pectoris, myocardial infarction within 3 months, heart failure 5.Uncontrolled diabetes mellitus, hypertension, infection 6.Pulmonary fibrosis detectable on chest X ray films 7.Concomitant malignancy 8.Pregnant or milk-feeding female 9.Symptomatic brain metastasis 10.Other clinical difficulties to this study
研究者
相似试验
已完成
2 期
Phase II study of amrubicin for previously treated advanced non-small cell lung cancerRecurrent non-small cell lung cancerJPRN-UMIN000001751Gunma University Hospital35
已完成
2 期
A phase II study of amrubicin for previously treated small cell lung cancerFor patients with recurrent small cell lung cancerJPRN-UMIN000001752Gunma University Hospital35
未知
不适用
A phase II study of Amrubicin in patients with previously treated small cell lung cancersmall cell lung cancerJPRN-C000000141Kinki University School of Medicine30
已完成
2 期
Phase 2 Study of Amrubicin for patients with recurrent advanced squamous cell lung cancer after first line treatment.Recurrent squamous cell lung cancerJPRN-UMIN000006270Kansai Medical University Hirakata Hospital40
已完成
不适用
Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based ChemotherapyAll patients had histologocally or cytologically confirmed locally advanced (non-irradiated) or metastatic NSCLC, with failure of platinum-based chemotherapy (exception for UFT and gefitinib).JPRN-C000000071West Japan Oncology Group60